← Back to Clinical Trials
Recruiting NCT06633120

NCT06633120 In Vitro Maturation of Human Eggs

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06633120
Status Recruiting
Phase
Sponsor Colorado Center for Reproductive Medicine
Condition Healthy
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2023-02-03
Primary Completion 2029-07-31

Eligibility & Interventions

Sex Female only
Min Age N/A
Max Age 38 Years
Study Type INTERVENTIONAL
Interventions
IVM

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2023-02-03 with a primary completion date of 2029-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

CCRM Fertility, a global pioneer in fertility treatment, research and science, is seeking participants for a new study on in vitro maturation (IVM). IVM requires less hormones to stimulate the ovaries than IVF, making it more affordable than IVF with fewer side effects. Participants that qualify for the study will receive a free cycle of IVM treatment at CCRM Fertility and including a new patient consultation, fertility testing, preimplantation genetic testing for aneuploidies (PGT-A), anesthesia and some medication

Eligibility Criteria

Inclusion Criteria: * Infertile women diagnosed with PCOS or polycystic ovaries, or infertile women with good ovarian reserve * Antral follicle count (AFC) greater than 24 * AMH greater than 3.5 ng/ml * Body Mass Index less than 35 * Accept to have embryos biopsied for PGT * Intend to perform embryo transfer within 4 months after completing the IVM cycle * Paternal (or donor) age \<45, ejaculated sperm collection only (partner frozen and donor sperm acceptable), sperm morphology (strict criteria) \>1%, motility \> 20% and sperm count \> 10 million per ml (so samples can be prepared through standard procedure) Exclusion Criteria: * More than 2 failed IVF cycles

Contact & Investigator

Central Contact

Elizabeth A Jannaman, BS

✉ EJannaman@CCRMIVF.com

📞 303-788-8300

Frequently Asked Questions

Who can join the NCT06633120 clinical trial?

This trial is open to female participants only, up to 38 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06633120 currently recruiting?

Yes, NCT06633120 is actively recruiting participants. Contact the research team at EJannaman@CCRMIVF.com for enrollment information.

Where is the NCT06633120 trial being conducted?

This trial is being conducted at Lone Tree, United States.

Who is sponsoring the NCT06633120 clinical trial?

NCT06633120 is sponsored by Colorado Center for Reproductive Medicine. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology